matched placebo for test product, Duvakitug clinical trials

A Multicenter, Multinational, Randomized, Double-blind, Placebo-Controlled, Phase 3 Maintenance Study to Evaluate the Efficacy and Safety of Duvakitug in Participants with Moderately to Severely Active Ulcerative Colitis

This study is testing a new medicine called Duvakitug for people with moderate to severe ulcerative colitis. It aims to see if Duvakitug can help keep symptoms in remission (controlled) and improve quality of life compared to a dummy medicine.